HERON THERAPEUTICS, INC. /DE/ Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent of -$51.31 million for the 3-month period ending 2018-12-31, per its 10-K filed 2019-02-22.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromContinuingOperations · last filed 2019-02-22
- HERON THERAPEUTICS, INC. /DE/ income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2018-12-31 was -$51.31M.
- HERON THERAPEUTICS, INC. /DE/ income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2018-09-30 was -$41.78M.
- HERON THERAPEUTICS, INC. /DE/ income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2018-06-30 was -$38.85M.
- HERON THERAPEUTICS, INC. /DE/ income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2018-03-31 was -$51.99M.
- HERON THERAPEUTICS, INC. /DE/ income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2014 was -$76.37M.
- HERON THERAPEUTICS, INC. /DE/ income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2013 was -$55.28M.
- HERON THERAPEUTICS, INC. /DE/ income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2012 was -$24.43M.
- HERON THERAPEUTICS, INC. /DE/ income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2011 was -$11.44M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 6 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 9 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|
| 2018-12-31 | -$51.31M 10-K · filed 2019-02-22 | -$93.09M derived: sum of 2 quarters · filed 2019-02-22 | -$131.95M derived: sum of 3 quarters · filed 2019-02-22 | -$183.94M derived: sum of 4 quarters · filed 2019-02-22 | |
| 2018-09-30 | -$41.78M 10-K · filed 2019-02-22 | -$80.63M derived: sum of 2 quarters · filed 2019-02-22 | -$132.62M derived: sum of 3 quarters · filed 2019-02-22 | -$194.51M derived: sum of 4 quarters · filed 2019-02-22 | |
| 2018-06-30 | -$38.85M 10-K · filed 2019-02-22 | -$90.84M derived: sum of 2 quarters · filed 2019-02-22 | -$152.73M derived: sum of 3 quarters · filed 2019-02-22 | -$194.05M derived: sum of 4 quarters · filed 2019-02-22 | |
| 2018-03-31 | -$51.99M 10-K · filed 2019-02-22 | -$113.88M derived: sum of 2 quarters · filed 2019-02-22 | -$155.19M derived: sum of 3 quarters · filed 2019-02-22 | -$197.25M derived: sum of 4 quarters · filed 2019-02-22 | |
| 2017-12-31 | -$61.89M 10-K · filed 2019-02-22 | -$103.20M derived: sum of 2 quarters · filed 2019-02-22 | -$145.26M derived: sum of 3 quarters · filed 2019-02-22 | -$194.56M derived: sum of 4 quarters · filed 2019-02-22 | |
| 2017-09-30 | -$41.31M 10-K · filed 2019-02-22 | -$83.37M derived: sum of 2 quarters · filed 2019-02-22 | -$132.67M derived: sum of 3 quarters · filed 2019-02-22 | -$179.47M derived: sum of 4 quarters · filed 2019-02-22 | |
| 2017-06-30 | -$42.05M 10-K · filed 2019-02-22 | -$91.35M derived: sum of 2 quarters · filed 2019-02-22 | -$138.16M derived: sum of 3 quarters · filed 2019-02-22 | -$185.89M derived: sum of 4 quarters · filed 2019-02-22 | |
| 2017-03-31 | -$49.30M 10-K · filed 2019-02-22 | -$96.10M derived: sum of 2 quarters · filed 2019-02-22 | -$143.84M derived: sum of 3 quarters · filed 2019-02-22 | -$186.90M derived: sum of 4 quarters · filed 2019-02-22 | |
| 2016-12-31 | -$46.80M 10-K · filed 2018-02-27 | -$94.54M derived: sum of 2 quarters · filed 2018-02-27 | -$137.60M derived: sum of 3 quarters · filed 2018-02-27 | -$170.91M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-09-30 | -$47.73M 10-K · filed 2018-02-27 | -$90.80M derived: sum of 2 quarters · filed 2018-02-27 | -$124.11M derived: sum of 3 quarters · filed 2018-02-27 | -$155.17M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | -$43.07M 10-K · filed 2018-02-27 | -$76.38M derived: sum of 2 quarters · filed 2018-02-27 | -$107.44M derived: sum of 3 quarters · filed 2018-02-27 | -$129.93M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | -$33.31M 10-K · filed 2018-02-27 | -$64.37M derived: sum of 2 quarters · filed 2018-02-27 | -$86.86M derived: sum of 3 quarters · filed 2018-02-27 | -$109.88M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2015-12-31 | -$31.06M 10-K · filed 2017-02-23 | -$53.55M derived: sum of 2 quarters · filed 2017-02-23 | -$76.56M derived: sum of 3 quarters · filed 2017-02-23 | -$96.92M derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-09-30 | -$22.49M 10-K · filed 2017-02-23 | -$45.51M derived: sum of 2 quarters · filed 2017-02-23 | -$65.86M derived: sum of 3 quarters · filed 2017-02-23 | -$85.36M derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-06-30 | -$23.01M 10-K · filed 2017-02-23 | -$43.37M derived: sum of 2 quarters · filed 2017-02-23 | -$62.87M derived: sum of 3 quarters · filed 2017-02-23 | -$81.82M derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-03-31 | -$20.36M 10-K · filed 2017-02-23 | -$39.85M derived: sum of 2 quarters · filed 2017-02-23 | -$58.81M derived: sum of 3 quarters · filed 2017-02-23 | -$77.60M derived: sum of 4 quarters · filed 2017-02-23 | |
| 2014-12-31 | -$19.50M 10-K · filed 2016-02-19 | -$38.45M derived: sum of 2 quarters · filed 2016-02-19 | -$57.24M derived: sum of 3 quarters · filed 2016-02-19 | -$76.37M 10-K · filed 2015-03-13 | |
| 2014-09-30 | -$18.95M 10-K · filed 2016-02-19 | -$37.74M derived: sum of 2 quarters · filed 2016-02-19 | -$55.07M derived: sum of 3 quarters · filed 2016-02-19 | -$68.90M derived: sum of 4 quarters · filed 2016-02-19 | |
| 2014-06-30 | -$18.79M 10-K · filed 2016-02-19 | -$36.11M derived: sum of 2 quarters · filed 2016-02-19 | -$49.94M derived: sum of 3 quarters · filed 2016-02-19 | -$62.61M derived: sum of 4 quarters · filed 2016-02-19 | |
| 2014-03-31 | -$17.32M 10-K · filed 2016-02-19 | -$31.15M derived: sum of 2 quarters · filed 2016-02-19 | -$43.82M derived: sum of 3 quarters · filed 2016-02-19 | -$59.03M derived: sum of 4 quarters · filed 2016-02-19 | |
| 2013-12-31 | -$13.83M 10-K · filed 2015-03-13 | -$26.50M derived: sum of 2 quarters · filed 2015-03-13 | -$41.70M derived: sum of 3 quarters · filed 2015-03-13 | -$55.28M 10-K · filed 2015-03-13 | |
| 2013-09-30 | -$12.66M 10-K · filed 2015-03-13 | -$12.87M 10-Q · filed 2013-11-12 | -$27.87M derived: sum of 2 quarters · filed 2015-03-13 | -$41.24M 10-Q · filed 2013-11-12 | -$49.65M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | -$15.21M 10-K · filed 2015-03-13 | -$15.41M 10-Q · filed 2013-08-08 | -$28.37M 10-Q · filed 2013-08-08 | -$36.99M derived: sum of 3 quarters · filed 2015-03-13 | -$43.24M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | -$12.95M 10-Q · filed 2013-05-10 | -$21.78M derived: sum of 2 quarters · filed 2014-03-07 | -$28.03M derived: sum of 3 quarters · filed 2014-03-07 | -$32.55M derived: sum of 4 quarters · filed 2014-03-07 | |
| 2012-12-31 | -$8.82M 10-K · filed 2014-03-07 | -$15.07M derived: sum of 2 quarters · filed 2014-03-07 | -$19.60M derived: sum of 3 quarters · filed 2014-03-07 | -$24.43M 10-K · filed 2015-03-13 | |
| 2012-09-30 | -$6.25M 10-K · filed 2014-03-07 | -$10.78M derived: sum of 2 quarters · filed 2014-03-07 | -$15.61M 10-Q · filed 2013-11-12 | -$27.69M derived: sum of 4 quarters · filed 2015-03-13 | |
| 2012-06-30 | -$4.53M 10-K · filed 2014-03-07 | -$9.36M 10-Q · filed 2013-08-08 | -$21.44M derived: sum of 3 quarters · filed 2015-03-13 | -$25.59M derived: sum of 4 quarters · filed 2015-03-13 | |
| 2012-03-31 | -$12.75M 10-K · filed 2015-03-13 | -$4.83M 10-K · filed 2013-03-01 | -$16.92M derived: sum of 2 quarters · filed 2015-03-13 | -$21.07M derived: sum of 3 quarters · filed 2015-03-13 | -$22.87M derived: sum of 4 quarters · filed 2015-03-13 |
| 2011-12-31 | -$4.17M 10-K · filed 2013-03-01 | -$8.32M derived: sum of 2 quarters · filed 2013-03-01 | -$10.12M derived: sum of 3 quarters · filed 2013-03-01 | -$11.44M 10-K · filed 2014-03-07 | |
| 2011-09-30 | -$4.15M 10-K · filed 2013-03-01 | -$5.95M derived: sum of 2 quarters · filed 2013-03-01 | -$7.27M 10-Q · filed 2012-11-05 | -$8.76M derived: sum of 4 quarters · filed 2013-03-01 | |
| 2011-06-30 | -$1.80M 10-K · filed 2013-03-01 | -$3.12M 10-Q · filed 2012-08-09 | -$4.61M derived: sum of 3 quarters · filed 2013-03-01 | -$6.25M derived: sum of 4 quarters · filed 2013-03-01 | |
| 2011-03-31 | -$1.32M 10-K · filed 2013-03-01 | -$2.81M derived: sum of 2 quarters · filed 2013-03-01 | -$4.45M derived: sum of 3 quarters · filed 2013-03-01 | -$8.14M derived: sum of 4 quarters · filed 2013-03-01 | |
| 2010-12-31 | -$1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$3.13M derived: sum of 2 quarters · filed 2013-03-01 | -$6.82M derived: sum of 3 quarters · filed 2013-03-01 | -$7.20M 10-K · filed 2013-03-01 | |
| 2010-09-30 | -$1.64M 10-Q · filed 2011-11-07 | -$5.33M derived: sum of 2 quarters · filed 2011-11-07 | -$5.70M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | -$3.69M 10-Q · filed 2011-08-08 | -$4.07M 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | -$10.10M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |